Clinic Attendance of Youth With Sickle Cell Disease on Hydroxyurea Treatment

被引:4
|
作者
Ingerski, Lisa M. [1 ]
Arnold, Trisha L. [1 ]
Banks, Gabrielle [1 ]
Porter, Jerlym S. [1 ]
Wang, Winfred C. [2 ]
机构
[1] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA
关键词
sickle cell disease; hydroxyurea; clinic attendance; adherence; QUALITY-OF-LIFE; CHILDREN; ADHERENCE; HEALTH; APPOINTMENTS; CARE; SURVIVORS; BARRIERS; BEHAVIOR; OUTCOMES;
D O I
10.1097/MPH.0000000000000859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The objective of this study is to describe rates of clinic attendance of youth with sickle cell disease prescribed hydroxyurea and examine potential demographic and medical factors related to consistent clinic attendance. Methods: Participants included 148 youth diagnosed with sickle cell disease and prescribed hydroxyurea during a single calendar year. Clinic attendance and potential demographic and medical factors related to attendance were extracted via systematic retrospective medical chart review. Results: Youth attended 90.3% of scheduled appointments and 85.1% of youth attended at least 80% of scheduled clinic appointments during the study window. Adjusting for other factors, multivariate analysis revealed families with fewer children in the household, families with private insurance, youth experiencing fever, and youth not experiencing pain during the calendar year were more likely to consistently attend clinic visits. Conclusions: Adherence to clinic appointments is critical to optimizing health outcomes for youth with sickle cell disease and integral for adequate monitoring of youth prescribed hydroxyurea, in particular. Findings may aid providers in appropriately identifying possible barriers to clinic attendance to develop attendance promotion interventions.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 50 条
  • [1] IMPACT OF CAREGIVER COPING ON YOUTH CLINIC ATTENDANCE AND HRQOL IN PEDIATRIC SICKLE CELL DISEASE
    Koskela-Staples, Natalie
    Evans, Corinne T.
    Turner, Elise
    Fedele, David
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 : S269 - S269
  • [2] HYDROXYUREA FOR THE TREATMENT OF SICKLE-CELL DISEASE
    ELHAZMI, MAF
    WARSY, AS
    ALMOMEN, A
    HARAKATI, M
    [J]. ACTA HAEMATOLOGICA, 1992, 88 (04) : 170 - 174
  • [3] Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease
    Badawy, Sherif M.
    Thompson, Alexis A.
    Holl, Jane L.
    Penedo, Frank J.
    Liem, Robert I.
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 35 (5-6) : 297 - 308
  • [4] Hydroxyurea for Treatment of Sickle Cell Disease in Adults in Africa
    Akingbola, Titilola S.
    Saraf, Santosh L.
    Shah, Binal N.
    Ezekekwu, Chinedu Anthony
    Sonubi, Omowunmi
    Hsu, Lewis L.
    Cooper, Richard S.
    Gordeuk, Victor R.
    Tayo, Bamidele O.
    [J]. BLOOD, 2016, 128 (22)
  • [5] Hydroxyurea in sickle cell disease
    Schechter, AN
    Rodgers, GP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05): : 333 - 333
  • [6] Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease
    Green, Nancy S.
    Manwani, Deepa
    Aygun, Banu
    Appiah-Kubi, Abena
    Smith-Whitley, Kim
    Castillo, Yina
    Soriano, Lucy
    Jia, Haomiao
    Smaldone, Arlene M.
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 (04)
  • [7] Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
    Al Sabbah, Mohammed Ali
    Radaideh, Mahmoud
    Saleh, Shafeeka Mohammed
    Al-Doory, Sura Ahmed
    Abdalqader, Amal Mahmoud
    Mir, Fatima Farid
    Mohammed, Aya
    [J]. DUBAI MEDICAL JOURNAL, 2023, 6 (04): : 301 - 305
  • [8] Parents' assessment of risk in sickle cell disease treatment with hydroxyurea
    Meyappan, JD
    Lampl, M
    Hsu, LL
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (12) : 644 - 650
  • [9] Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
    Lanzkron, Sophie
    Strouse, John J.
    Wilson, Renee
    Beach, Mary Catherine
    Haywood, Carlton
    Park, HaeSong
    Witkop, Catherine
    Bass, Eric B.
    Segal, Jodi B.
    [J]. ANNALS OF INTERNAL MEDICINE, 2008, 148 (12) : 939 - +
  • [10] Cellular Biophysical Markers of Hydroxyurea Treatment in Sickle Cell Disease
    So, Peter T. C.
    Hosseini, Poorya
    Abidi, Sabia Z.
    Du, E.
    Papageorgiou, Dimitrios P.
    Park, YongKeun
    Higgins, John
    Kato, Gregory J.
    Suresh, Subra
    Dao, Ming
    Yaqoob, Zahid
    [J]. BIOMEDICAL IMAGING AND SENSING CONFERENCE, 2017, 10251